CAPSTONE INVESTMENT ADVISORS, LLC - AMAG PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$2,716,000
-23.0%
3,000,000
-33.3%
0.01%
-39.1%
Q2 2020$3,529,000
+1.5%
4,500,0000.0%0.02%
-58.9%
Q1 2020$3,477,000
-31.3%
4,500,000
-25.0%
0.06%
+107.4%
Q4 2019$5,063,000
+2.3%
6,000,0000.0%0.03%
-20.6%
Q3 2019$4,950,000
-35.1%
6,000,000
-36.8%
0.03%
-38.2%
Q2 2019$7,627,000
+22.1%
9,500,000
+46.2%
0.06%
-67.6%
Q2 2017$6,248,0006,500,0000.17%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 1,500,000$1,492,0002.87%
Telemetry Investments, L.L.C. 8,000,000$7,780,0002.78%
Context Capital Management, LLC 3,500,000$3,405,0002.28%
Kamunting Street Capital Management, L.P. 2,500,000$2,431,0001.54%
BASSO CAPITAL MANAGEMENT, L.P. 12,205,000$11,824,0001.46%
TENOR CAPITAL MANAGEMENT Co., L.P. 17,500,000$17,269,0001.34%
CAMDEN ASSET MANAGEMENT L P /CA 32,375,000$31,485,0001.04%
Jabre Capital Partners S.A. 5,500,000$5,328,0001.04%
City Financial Investment Co Ltd 12,500,000$12,168,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 16,250,000$15,747,0000.71%
View complete list of AMAG PHARMACEUTICALS INC shareholders